Joe Russo Joins AAM as Senior Director, Federal Government Affairs | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks to David Gaugh (AAM), Jessica Daley (Premier Inc) and Steven Schondelmeyer (University of Minnesota).

Joe Russo Joins AAM as Senior Director, Federal Government Affairs

Joe Russo – Senior Director, Federal Government Affairs

WASHINGTON, D.C. (August 10, 2021) — Today Joe Russo is joining the Association for Accessible Medicines as Senior Director, Federal Government Affairs. Joe will help develop the association’s strategy and implement the initiatives of AAM’s government affairs department. He is responsible for managing a range of government relations initiatives and projects to promote the federal policy goals and objectives of AAM.

Joe has a solid record of coalition building, said Katherine Raab, Vice President, Federal Affairs. We are excited to have the opportunity to expand our reach.

Before joining AAM, Joe served in the White House, most recently as Special Assistant to the President and Deputy Director of the Office of Public Liaison. Previously, he was Coalitions Director of the House Judiciary Committee and served on the legislative staff of Representative Bob Goodlatte (R-VA).

Joe earned his BA in Political Science at James Madison University.

View Bio


Rachel Schwartz


About AAM

AAM is driven by the belief that access to safe, quality, effective medicine has a tremendous impact on a person’s life and the world around them. Generic and biosimilar medicines improve people’s lives, improving society and the economy in turn. AAM represents the manufacturers and distributors of finished generic pharmaceuticals and biosimilars, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals are 90 percent of prescriptions dispensed in the U.S. but only 20 percent of total drug spending. 

About the Biosimilars Council

The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), works to ensure a positive environment for patient access to biosimilar medicines. The Biosimilars Council is a leading source for information about the safety and efficacy of more affordable alternatives to costly brand biologic medicines. Areas of focus include public and health expert education, strategic partnerships, government affairs, legal affairs and regulatory policy. More information is available at

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.